Clinical Trials Directory

Trials / Unknown

UnknownNCT04245098

Carpal Tunnel Syndrome and Amyloidosis

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Corporacion Parc Tauli · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Carpal tunnel syndrome has been suggested to be an early sign of amyloidosi. The investigators will evaluate tissue samples obtained from patients undergoing carpal tunnel release surgery for amyloid.

Detailed description

Carpal tunnel syndrome (CTS) can be caused by the deposition and accumulation of misfolded proteins called amyloid and is often an early manifestation of systemic amyloidosis. Patients with cardiac amyloidosis often have carpal tunnel syndrome that precedes cardiac manifestations by several years, and many patients will have undergone surgery for idiopathic carpal tunnel syndrome since the protein also deposits in the transversal carpal ligament of the hand. The investigators sought to identify the prevalence and type of amyloid deposits in patients undergoing carpal tunnel surgery and evaluate for cardiac involvement

Conditions

Interventions

TypeNameDescription
PROCEDURECarpal tunnel syndrome surgeryBiopsy

Timeline

Start date
2020-01-08
Primary completion
2022-01-08
Completion
2023-01-08
First posted
2020-01-28
Last updated
2020-01-28

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT04245098. Inclusion in this directory is not an endorsement.

Carpal Tunnel Syndrome and Amyloidosis (NCT04245098) · Clinical Trials Directory